Day One Biopharmaceutical Stock (NASDAQ: DAWN) stock price, news, charts, stock research, profile.
You can purchase shares of Day One Biopharmaceutical (NASDAQ:DAWN) through any online brokerage.
Other companies in Day One Biopharmaceutical’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Upstream Bio (NASDAQ:UPB), Syndax Pharmaceuticals (NASDAQ:SNDX) and Xencor (NASDAQ:XNCR).
Day One Biopharmaceutical has a consensus price target of $36.50.
The stock price for Day One Biopharmaceutical (NASDAQ: DAWN) is $16.3 last updated November 8, 2024 at 5:52 PM EST.
There are no upcoming dividends for Day One Biopharmaceutical.
Day One Biopharmaceutical’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
There is no upcoming split for Day One Biopharmaceutical.
Day One Biopharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.